CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题：Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma.
Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
过去数年，多发性骨髓瘤的治疗取得重大进展。然而，骨髓瘤仍无法治愈；具有高危细胞遗传学特征或疾病晚期患者的生存情况更差。对部分患者而言，只有异体移植可能具有治愈潜力。然而，较高的非复发死亡率和慢性移植物抗宿主病发生率，使这一治疗方式备受争议。本综述将讨论一线及延迟实施异体移植的作用。
Major progress in the treatment of multiple myeloma has been made in the last several years.
However, myeloma remains incurable and patients with high-risk cytogenetics or advanced stage disease have an even worsen survival. Only allogeneic transplantation may have curative potential in some patients.
However, the high non-relapse mortality and incidence of chronic graft-versus-host disease have raised controversy regarding this procedure. In this review, we will address the role of upfront and delayed allogeneic transplant.
在 PubMed 查看 → 出版商原文（DOI） 全文 PDF（PMC）· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。
